Sunshine Lake Pharma Co (HKSE:06887) Beta: N/A (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06887 Sunshine Lake Pharma Co Ltd HKSE:06887
15 GF Score
Price HK$37.98
! 2 Warning Signs
View Full Analysis

What is Sunshine Lake Pharma Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-21), Sunshine Lake Pharma Co's Beta is Not available.

Sunshine Lake Pharma Co  (HKSE:06887) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Sunshine Lake Pharma Co Beta Related Terms

Sunshine Lake Pharma Co Beta Historical Data

* Premium members only.

The historical data trend for Sunshine Lake Pharma Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Lake Pharma Co Beta Chart

Sunshine Lake Pharma Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beta
0.00 0.00 0.00 0.00

Sunshine Lake Pharma Co Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
HKSE:06887
15GF Score
Sunshine Lake Pharma Co Ltd HKSE:06887
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Lake Pharma Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Sunshine Lake Pharma Co Business Description

Address No. 368 Zhen An Zhong Road, HEC Scientific Park, Chang’an County, Guangdong Province, Dongguan, CHN
Sunshine Lake Pharma Co Ltd is a vertically integrated pharmaceutical company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. It is focused on therapeutic areas of infectious diseases, chronic diseases and oncology. The company's revenue is mainly derived from sales of pharmaceutical products to distributors in the PRC.
15GF Score

Get the complete analysis for HKSE:06887

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$37.98
Price